Photopheresis Products Market Size, Share, Trends, Growth, Consumption, Revenue, Company Analysis and Forecast 2021-2027

The global photopheresis products market size surpassed US$ 262 million in 2019 and expected to reach US4 435 million by 2027 with a CAGR of above 5.5% from 2020 to 2027.

Photopheresis products are mainly used to treat cutaneous T-cell lymphoma conditions. In the photopheresis treatment procedure white blood cells are collected from the blood and they are mixed with photosensitizer and treated with UV light. New therapeutic indications options are boosting the growth of this market.

Furthermore, photopheresis therapy is majorly used in treating the patients who are not responding to steroids therapy in transplant rejection conditions. Photopheresis therapy is safer therapy when compared with steroids due to lack of side effects.

North America dominated the global photopheresis therapy market in 2018 and the trend is anticipated to continue during the forecast period, As Governments provide reimbursement for various disease indications such as GVHD, CTL, and lung transplantations that are treated by ECP therapy.

Corporate entities boosting the research activities on ECP therapy to Drive Photopheresis Products Market

  • Corporates are actively encouraging research on photopheresis treatment by providing monetary support to researchers.
  • In 2014, Freseinus Kabi conducted an award contest on advanced research in therapeutic apheresis and cell therapy. The company has granted US$ 100,000 to the research team led by John Koreth, Dana Farber Cancer Institute, for his work on treating chronic GvHD condition by using photopheresis and low-dose interleukin-2 (IL-2).

 Closed System Segment to Capture Largest Market Share

  • Based on product, closed system devices has the highest revenue as compared to open systems and is expected to be dominate over the forecast period in 2019, as closed photopheresis system is the only FDA approved system to treat CTL conditions.

 Graft versus host disease to dominate Market in Term of Therapeutic Application

  • Based on therapeutic area, the market has been segmented into cutaneous T-cell lymphoma, graft versus host disease, transplant rejections and autoimmune diseases. Graft versus host disease is expected to dominate the market over the forecast period due to increase in allogeneic stem cell transplantations worldwide. In addition to that, increase in usage of photopheresis therapy in organ transplantations are boosting the growth of this market over the forecast period

Hospital to be Highly Lucrative Segment

  • Based on end-user, the global photopheresis products market has been divided into hospitals and specialty clinics. The hospitals segment is anticipated to expand at the highest CAGR during the forecast period. Availability of multiple treatments options in hospitals enables patients to opt more for hospitals than specialty clinics.

North America to Dominate Global Market

  • In terms of region, the global photopheresis products market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global photopheresis products market in 2019, followed by Europe.
  • The growth of the photopheresis products market in North America is attributed to the favorable reimbursement scenario and increasing prevalence of cutaneous T cell lymphoma and GvHD conditions. In 2012, Medicare extended reimbursement coverage for ECP therapy to treat bronchiolitis obliterans syndrome (BOS), a chronic lung allograft transplant dysfunction in the U.S.

Competitive Landscape

  • Companies have developed advanced photopheresis medical devices to overcome the problems of conventional medical devices. Conventional photopheresis systems are more prone to cause infections, leakage problems, and prolonged treatment time. Hence, companies are using advanced medical devices to overcome these problems.
  • Key players in the global market include Macopharma, Med Tech Solutions GmbH, Haemonetics Corporation, Fresenius Kabi AG, Terumo Corporation, and Mallinckrodt Pharmaceuticals among others among others.

The global photopheresis products market has been segmented as follows:

Global Photopheresis products Market, by Product

  • Open system
  • Closed system

Global Photopheresis Products market, by Therapeutic Area

  • Graft versus host disease
  • Transplant rejections
  • Autoimmune diseases
  • Cutaneous T-cell lymphoma

Global Photopheresis Products market, by End User

  • Hospitals
  • Specialty clinics

Global Photopheresis Products Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Scope of Report

VRR’s report on the global photopheresis products market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030. The report provides revenue of the global photopheresis products market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global photopheresis products market during the forecast period.

The report has been prepared after extensive primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players, Product Type literature, annual reports, press releases, and relevant documents to understand the global photopheresis products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global photopheresis products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global photopheresis products market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global photopheresis products market.

The report delves into the competitive landscape of the global photopheresis products market. Key players operating in the global photopheresis products market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global photopheresis products market that have been profiled in this report.

Key Questions Answered in Global Photopheresis Products Market Report

  • What is the scope of growth of product type companies in the global photopheresis products market?
  • What will be the Y-o-Y growth of the global photopheresis products market between 2020 and 2030?
  • Will North America continue to be the most profitable market for photopheresis products providers?
  • Which factors are anticipated to hamper the growth of the global photopheresis products market during the forecast period?
  • Which are the leading companies in the global photopheresis products market?

Research Methodology

A unique research methodology has been utilized by VRR to conduct comprehensive research on the growth of the global photopheresis products market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary researches, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary sources referred to by analysts during the product type of the global photopheresis products market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, Product Type portfolio managers, and market intelligence managers, who contributed to VRR’s study on the photopheresis products market as primary research sources.

These primary and secondary research sources have provided exclusive information during interviews, which serves as a validation from the photopheresis products market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global photopheresis products market with accuracy. The study also uses the top-down approach to assess the revenues for each segment and the bottom-up approach to counter-validate them. This has helped in reaching VRR’s estimates on future prospects of the global photopheresis products market more reliably and accurately.

Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Photopheresis Market

4. Market Overview

4.1. Introduction

4.1.1. By Product Definition

4.1.2. Industry Evolution / Developments

4.2.  Overview

4.3. Key Market Indicators

4.3.1. Region/Country Specific

4.3.2. Product/Application/Therapeutic Area Specific

4.3.3. Target Market Specific – Global Scenario

4.4. Market Dynamics

4.4.1. Drivers

4.4.2. Restraints

4.4.3. Opportunity

4.4.Global Photopheresis Products Market Forecast, 2018-2027

4.4.1.Market Size Forecast

4.4.2.Pipeline Analysis

4.5.Organ and Stem Cell Transplantations Overview

4.6.Photopheresis Therapy Snapshot

4.7. Global Photopheresis Market Analysis and Forecasts, 2018-2027

4.7.1. Market Revenue Projections (US$ Mn)

4.8. Photopheresis Market - Global Supply Demand Scenario

4.9. Porter’s Five Force Analysis

4.10. Market Outlook

5. Global Photopheresis Market Analysis and Forecasts, By Product

5.1. Introduction & Definition

5.2. Key Findings / Developments

5.3. Key Trends

5.4. Market value  Forecast By Product, 2018-2027

5.4.1. Open ECP system

5.4.2. Closed ECP system

5.5. By Product Comparison Matrix

5.6. Market Attractiveness By Product

6. Global Photopheresis Market Analysis and Forecasts, By End User

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Key Trends

6.4. Market value  Forecast By End User, 2018-2027

6.4.1. Hospitals

6.4.2. Specialty Clinics

6.5. End User  Comparison Matrix

6.6. Market Attractiveness By End User

7. Global Photopheresis Market Analysis and Forecasts, By Therapeutic Area

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Key Trends

7.4. Market value  Forecast By Therapeutic Area, 2018-2027

7.4.1. Cutaneous T-cell Lymphoma

7.4.2. Graft-versus-Host Disease

7.4.3. Transplantation rejection

7.4.4. Autoimmune Disease

7.5. Therapeutic Area  Comparison Matrix

7.6. Market Attractiveness By Therapeutic Area

8. Global Photopheresis Market Analysis and Forecasts, By Region

8.1. Key Findings

8.2. Policies and Regulations

8.3. Market value  Forecast By Region

8.3.1. North America

8.3.2. Latin America

8.3.3. APAC

8.3.4. Europe

8.3.5. MEA

8.4. Market Attractiveness By Country/Region

9. North America Photopheresis Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.1.2. Policies and Regulations

9.1.3. Price Trend Analysis

9.1.4. Key Trends

9.2. Market value  Forecast By Product, 2018-2027

9.2.1. Open ECP system

9.2.2. Closed ECP system

9.3. Market value  Forecast By End User, 2018-2027

9.3.1. Hospitals

9.3.2. Specialty Clinics

9.4. Market value  Forecast By Therapeutic Area, 2018-2027

9.4.1. Cutaneous T-cell Lymphoma

9.4.2. Graft-versus-Host Disease

9.4.3. Transplantation rejection

9.4.4. Autoimmune Disease

9.5. Market value  Forecast By Country, 2018-2027

9.5.1. US

9.5.2. Canada

9.6. Market Attractiveness Analysis

9.6.1. By Product

9.6.2. By End User

9.6.3. By Therapeutic Area

9.6.4. By Country

10. Latin America Photopheresis Market Analysis and Forecast

10.1.Introduction

10.1.1. Key Findings

10.1.2. Policies and Regulations

10.1.3. Price Trend Analysis

10.1.4. Key Trends

10.2.Market value  Forecast By Product, 2018-2027

10.2.1. Open ECP system

10.2.2. Closed ECP system

10.3.Market value  Forecast By End User, 2018-2027

10.3.1. Hospitals

10.3.2. Specialty Clinics

10.4.Market value  Forecast By Therapeutic Area, 2018-2027

10.4.1. Cutaneous T-cell Lymphoma

10.4.2. Graft-versus-Host Disease

10.4.3. Transplantation rejection

10.4.4. Autoimmune Disease

10.5.Market value  Forecast By Country, 2018-2027

10.5.1. Brazil

10.5.2. Mexico

10.5.3. Rest of Latin America

10.6.Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By End User

10.6.3. By Therapeutic Area

10.6.4. By Country

11. APAC Photopheresis Market Analysis and Forecast

11.1.Introduction

11.1.1. Key Findings

11.1.2. Policies and Regulations

11.1.3. Price Trend Analysis

11.1.4. Key Trends

11.2.Market value  Forecast By Product, 2018-2027

11.2.1. Open ECP system

11.2.2. Closed ECP system

11.3.Market value  Forecast By End User, 2018-2027

11.3.1. Hospitals

11.3.2. Specialty Clinics

11.4.Market value  Forecast By Therapeutic Area, 2018-2027

11.4.1. Cutaneous T-cell Lymphoma

11.4.2. Graft-versus-Host Disease

11.4.3. Transplantation rejection

11.4.4. Autoimmune Disease

11.5.Market value  Forecast By Country, 2018-2027

11.5.1. Japan

11.5.2. India

11.5.3. China

11.5.4. Rest of APAC

11.6.Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By End User

11.6.3. By Therapeutic Area

11.6.4. By Country

12. Europe Photopheresis Market Analysis and Forecast

12.1.Introduction

12.1.1. Key Findings

12.1.2. Policies and Regulations

12.1.3. Price Trend Analysis

12.1.4. Key Trends

12.2.Market value  Forecast By Product, 2018-2027

12.2.1. Open ECP system

12.2.2. Closed ECP system

12.3.Market value  Forecast By End User, 2018-2027

12.3.1. Hospitals

12.3.2. Specialty Clinics

12.4.Market value  Forecast By Therapeutic Area, 2018-2027

12.4.1. Cutaneous T-cell Lymphoma

12.4.2. Graft-versus-Host Disease

12.4.3. Transplantation rejection

12.4.4. Autoimmune Disease

12.5.Market value  Forecast By Country, 2018-2027

12.5.1. UK

12.5.2. France

12.5.3. Germany

12.5.4. Spain

12.5.5. Italy

12.5.6. Russia

12.5.7. Rest of Europe

12.6.Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By End User

12.6.3. By Therapeutic Area

12.6.4. By Country

13. MEA Photopheresis Market Analysis and Forecast

13.1.Introduction

13.1.1. Key Findings

13.1.2. Policies and Regulations

13.1.3. Price Trend Analysis

13.1.4. Key Trends

13.2.Market value  Forecast By Product, 2018-2027

13.2.1. Open ECP system

13.2.2. Closed ECP system

13.3.Market value  Forecast By End User, 2018-2027

13.3.1. Hospitals

13.3.2. Specialty Clinics

13.4.Market value  Forecast By Therapeutic Area, 2018-2027

13.4.1. Cutaneous T-cell Lymphoma

13.4.2. Graft-versus-Host Disease

13.4.3. Transplantation rejection

13.4.4. Autoimmune Disease

13.5.Market value  Forecast By Country, 2018-2027

13.5.1. South Africa

13.5.2. Saudi Arabia

13.5.3. UAE

13.5.4. Rest of MEA

13.6.Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By End User

13.6.3. By Therapeutic Area

13.6.4. By Country

14. Competition Landscape

14.1.Market Player – Competition Matrix (By Tier and Size of companies)

14.2.Market Share Analysis By Company (2019)

14.3.Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)

14.3.1. Haemonetics Corporation

        14.3.1.1.Company Overview

        14.3.1.2.Financial Overview

        14.3.1.3.Product Portfolio

        14.3.1.4.Business Strategies

        14.3.1.5.Recent Developments

14.3.2. Fresenius Kabi AG

        14.3.2.1.Company Overview

        14.3.2.2.Financial Overview

        14.3.2.3.Product Portfolio

        14.3.2.4.Business Strategies

        14.3.2.5.Recent Developments

14.3.3. Macopharma

        14.3.3.1.Company Overview

        14.3.3.2.Financial Overview

        14.3.3.3.Product Portfolio

        14.3.3.4.Business Strategies

        14.3.3.5.Recent Developments

14.3.4. Terumo Corporation

        14.3.4.1.Company Overview

        14.3.4.2.Financial Overview

        14.3.4.3.Product Portfolio

        14.3.4.4.Business Strategies

        14.3.4.5.Recent Developments

14.3.5. Med Tech Solutions GmbH

        14.3.5.1.Company Overview

        14.3.5.2.Financial Overview

        14.3.5.3.Product Portfolio

        14.3.5.4.Business Strategies

        14.3.5.5.Recent Developments

14.3.6. Mallinckrodt Pharmaceuticals

        14.3.6.1.Company Overview

        14.3.6.2.Financial Overview

        14.3.6.3.Product Portfolio

        14.3.6.4.Business Strategies

        14.3.6.5.Recent Developments

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers